ArticlePloS one2012

Cost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillation.

Joyce H S You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.